Clinical Trials Browser

Small Cell Lung Carcinoma × oblimersen × Clear all

NCT00005032 2013-02-11

Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 1/2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00042978 2013-01-14

Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Completed

Small Cell Lung Carcinoma